To include your compound in the COVID-19 Resource Center, submit it here.

IFN-alpha kinoid: Preliminary Phase I/II data

Preliminary data from the double-blind, placebo-controlled, dose-escalation, European Phase I/II IFN-K-001 trial in 20 patients

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE